NCT02770521View on ClinicalTrials.gov

A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Healthy
Interventions
DRUG

Treprostinil

Administered SC.

DRUG

Placebo

Administered SC.

DRUG

LY900014

Administered SC.

DRUG

Insulin Lispro

Administered SC.

Trial Locations (1)

812-0025

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Fukuoka

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02770521 - A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants | Biotech Hunter | Biotech Hunter